ANVISA and WHO: QR Group Explains Impacts on Medical Product Regulation

How ANVISA’s role at the WHO influences the regulation of medical devices in Brazil The recent appointment of ANVISA as Brazil’s official representative on the Executive Board of the World Health Organization (WHO) has important implications for the regulation of medical devices in the country. With a strong technical performance, the Brazilian agency reinforces its […]
QR Group: How to Register Health Products with ANVISA and Ensure Compliance

Learn how QR Group can assist in the registration of health products with ANVISA and in the regulatory process to ensure entry into the Brazilian market. For a health product to be legally marketed in Brazil, it is essential that it goes through the registration process with ANVISA. This process involves a series of steps […]